Home > Healthcare > Medical Devices > Implantable Devices > annuloplasty system market
Get a free sample of Annuloplasty System Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Annuloplasty System Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The mitral valve repair application segment recorded USD 240.8 million in 2023 due to their ability to preserve valve function and mitigate risks associated with prosthetic devices.
Annuloplasty system market size was USD 473.9 million in 2023 and will grow at an 8.2% CAGR between 2024 and 2032, propelled by rising prevalence of valvular heart diseases, advancements in minimally invasive surgical techniques, and aging populationsworldwide.
North America annuloplasty system industry recorded USD 198.5 million in 2023 and will expand at 7.8% CAGR till 2032, owing to advanced healthcare infrastructure, high prevalence rates of cardiovascular diseases, and extensive adoption of innovative medical technologies.
Abbott Laboratories, Affluent Medical, BioStable Science & Engineering, Corcym UK Limited, Coroneo, Edwards Lifesciences Corporation, Genesee BioMedical, Medtentia International Ltd Oy, Medtronic plc, and Micro Interventional Devices Incorporated among others.